

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * B cell receptor signaling pathway (GO:0050853) | 9.09662274 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.50464454 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.45292214 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.53317567 |
| 5 | regulation of B cell differentiation (GO:0045577) | 6.49936530 |
| 6 | positive regulation of B cell differentiation (GO:0045579) | 6.31751389 |
| 7 | B cell proliferation (GO:0042100) | 6.10343063 |
| 8 | cellular response to zinc ion (GO:0071294) | 5.97592831 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.72248658 |
| 10 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.59779985 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.22317895 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.03667408 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.03667408 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.96306568 |
| 15 | negative regulation of histone methylation (GO:0031061) | 4.69085540 |
| 16 | mature B cell differentiation (GO:0002335) | 4.59786866 |
| 17 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 4.54823076 |
| 18 | regulation of antigen processing and presentation (GO:0002577) | 4.54546171 |
| 19 | regulation of B cell proliferation (GO:0030888) | 4.50737713 |
| 20 | negative regulation of B cell proliferation (GO:0030889) | 4.43445874 |
| 21 | detection of bacterium (GO:0016045) | 4.37905465 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32770912 |
| 23 | B cell mediated immunity (GO:0019724) | 4.32393434 |
| 24 | regulation of histone H3-K9 methylation (GO:0051570) | 4.14806908 |
| 25 | cellular response to interleukin-15 (GO:0071350) | 4.12544738 |
| 26 | regulation of B cell apoptotic process (GO:0002902) | 4.12163608 |
| 27 | regulation of superoxide anion generation (GO:0032928) | 4.12150684 |
| 28 | cytidine metabolic process (GO:0046087) | 4.12027137 |
| 29 | cytidine catabolic process (GO:0006216) | 4.12027137 |
| 30 | cytidine deamination (GO:0009972) | 4.12027137 |
| 31 | type I interferon signaling pathway (GO:0060337) | 4.08586197 |
| 32 | cellular response to type I interferon (GO:0071357) | 4.08586197 |
| 33 | response to type I interferon (GO:0034340) | 4.07668543 |
| 34 | response to interleukin-15 (GO:0070672) | 4.07320509 |
| 35 | B cell activation (GO:0042113) | 4.06697732 |
| 36 | detection of other organism (GO:0098543) | 4.06010016 |
| 37 | * antigen receptor-mediated signaling pathway (GO:0050851) | 4.05689518 |
| 38 | positive regulation of Rap GTPase activity (GO:0032854) | 4.02305379 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.01064770 |
| 40 | serine transport (GO:0032329) | 4.00121538 |
| 41 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.90189854 |
| 42 | B cell homeostasis (GO:0001782) | 3.83124969 |
| 43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.80211218 |
| 44 | modulation by symbiont of host defense response (GO:0052031) | 3.80211218 |
| 45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.80211218 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.80211218 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.80211218 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 3.80211218 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.79518394 |
| 50 | defense response to protozoan (GO:0042832) | 3.78826443 |
| 51 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.76873128 |
| 52 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.76389231 |
| 53 | lymphocyte homeostasis (GO:0002260) | 3.74365676 |
| 54 | positive regulation of B cell proliferation (GO:0030890) | 3.73829296 |
| 55 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.73724871 |
| 56 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.73375619 |
| 57 | negative regulation of phagocytosis (GO:0050765) | 3.73200697 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.70759726 |
| 59 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.69149124 |
| 60 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.63875855 |
| 61 | T cell selection (GO:0045058) | 3.62598752 |
| 62 | T cell homeostasis (GO:0043029) | 3.61943327 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.54765113 |
| 64 | L-serine transport (GO:0015825) | 3.53219657 |
| 65 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.52509028 |
| 66 | positive regulation of B cell activation (GO:0050871) | 3.52356408 |
| 67 | thymic T cell selection (GO:0045061) | 3.52110767 |
| 68 | B cell differentiation (GO:0030183) | 3.49823347 |
| 69 | negative regulation of B cell apoptotic process (GO:0002903) | 3.48469605 |
| 70 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47247315 |
| 71 | T cell migration (GO:0072678) | 3.46773768 |
| 72 | negative thymic T cell selection (GO:0045060) | 3.44322305 |
| 73 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.44230459 |
| 74 | T cell lineage commitment (GO:0002360) | 3.43571034 |
| 75 | positive regulation of histone deacetylation (GO:0031065) | 3.43336507 |
| 76 | mononuclear cell proliferation (GO:0032943) | 3.41203929 |
| 77 | positive T cell selection (GO:0043368) | 3.40857243 |
| 78 | lymphocyte proliferation (GO:0046651) | 3.40614099 |
| 79 | negative regulation of bone resorption (GO:0045779) | 3.40571277 |
| 80 | regulation of B cell activation (GO:0050864) | 3.39180829 |
| 81 | positive regulation of immunoglobulin production (GO:0002639) | 3.37686782 |
| 82 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.37279353 |
| 83 | immunoglobulin mediated immune response (GO:0016064) | 3.36737456 |
| 84 | lymph node development (GO:0048535) | 3.34852466 |
| 85 | germinal center formation (GO:0002467) | 3.34674796 |
| 86 | regulation of Rap GTPase activity (GO:0032317) | 3.32831166 |
| 87 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 3.31751104 |
| 88 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 3.31751104 |
| 89 | Fc-gamma receptor signaling pathway (GO:0038094) | 3.31751104 |
| 90 | mature B cell differentiation involved in immune response (GO:0002313) | 3.30628342 |
| 91 | neutrophil activation (GO:0042119) | 3.27619857 |
| 92 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 3.25864703 |
| 93 | positive regulation of type 2 immune response (GO:0002830) | 3.25317404 |
| 94 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.22676187 |
| 95 | leukocyte homeostasis (GO:0001776) | 3.22282231 |
| 96 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.21636656 |
| 97 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.20055444 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.20055444 |
| 99 | vesicle targeting (GO:0006903) | 3.18976545 |
| 100 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.15169076 |
| 101 | macrophage activation involved in immune response (GO:0002281) | 3.14879540 |
| 102 | regulation of germinal center formation (GO:0002634) | 3.14850729 |
| 103 | response to protozoan (GO:0001562) | 3.14287436 |
| 104 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.13550724 |
| 105 | positive regulation of humoral immune response (GO:0002922) | 3.12035043 |
| 106 | negative T cell selection (GO:0043383) | 3.11404793 |
| 107 | cellular response to interferon-gamma (GO:0071346) | 3.11067401 |
| 108 | positive regulation of interleukin-2 production (GO:0032743) | 3.09744941 |
| 109 | regulation of platelet aggregation (GO:0090330) | 3.08762652 |
| 110 | activation of JUN kinase activity (GO:0007257) | 3.07009931 |
| 111 | positive regulation of interferon-alpha production (GO:0032727) | 3.06690545 |
| 112 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05277316 |
| 113 | NIK/NF-kappaB signaling (GO:0038061) | 3.04269500 |
| 114 | leukocyte proliferation (GO:0070661) | 3.03469362 |
| 115 | V(D)J recombination (GO:0033151) | 3.02647678 |
| 116 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.01578242 |
| 117 | Peyers patch development (GO:0048541) | 2.99217904 |
| 118 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99217904 |
| 119 | T-helper 1 type immune response (GO:0042088) | 2.98940087 |
| 120 | leukocyte aggregation (GO:0070486) | 2.98474949 |
| 121 | T cell costimulation (GO:0031295) | 2.97878104 |
| 122 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.97799620 |
| 123 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.97766147 |
| 124 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96573966 |
| 125 | negative regulation of cell killing (GO:0031342) | 2.96573966 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.95335602 |
| 127 | detection of external biotic stimulus (GO:0098581) | 2.95054510 |
| 128 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.94526047 |
| 129 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92705708 |
| 130 | respiratory burst (GO:0045730) | 2.91749549 |
| 131 | lymphocyte costimulation (GO:0031294) | 2.90439728 |
| 132 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.89774616 |
| 133 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.89660010 |
| 134 | natural killer cell differentiation (GO:0001779) | 2.89355433 |
| 135 | regulation of interferon-alpha production (GO:0032647) | 2.88900572 |
| 136 | granulocyte activation (GO:0036230) | 2.88704301 |
| 137 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.88561230 |
| 138 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.88341825 |
| 139 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.88142521 |
| 140 | tolerance induction (GO:0002507) | 2.87150212 |
| 141 | myeloid dendritic cell activation (GO:0001773) | 2.87125631 |
| 142 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.83956451 |
| 143 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.83956451 |
| 144 | humoral immune response (GO:0006959) | 2.83086324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.72687810 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 5.41126729 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.12130337 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.46833524 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.24470906 |
| 6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.13087797 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.72283512 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.42719324 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.16014867 |
| 10 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.12840877 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.03563570 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.00236883 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.88742759 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75235409 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.69744242 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.62778074 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.54963846 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.54491161 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.49181838 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.46112926 |
| 21 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.44480145 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.37072547 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.33785978 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.31615708 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.18161892 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.13947384 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06565468 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06344495 |
| 29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02725580 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.00501826 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96289268 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.95406612 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.94697021 |
| 34 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91748480 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90415875 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.87407728 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71116510 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67351768 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.65550375 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63072795 |
| 41 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60248079 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59451110 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58452116 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57859278 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.52969316 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52813165 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51103113 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49926494 |
| 49 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48691566 |
| 50 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.46508592 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45883940 |
| 52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.44579109 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41707133 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41310416 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.38204145 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38117043 |
| 57 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38090254 |
| 58 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36678503 |
| 59 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36252780 |
| 60 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.35181064 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32509991 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28351699 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21345918 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18780981 |
| 65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12513947 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09397749 |
| 67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09114433 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.07919737 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07398486 |
| 70 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05630866 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.04818408 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04405926 |
| 73 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04106054 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.00691561 |
| 75 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99378473 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98154971 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96556145 |
| 78 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.96546945 |
| 79 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95333517 |
| 80 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94891831 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94793781 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94284351 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93713760 |
| 84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.90594505 |
| 85 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90105477 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89969157 |
| 87 | P300_27268052_Chip-Seq_Bcells_Human | 0.88963598 |
| 88 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.88552342 |
| 89 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88343588 |
| 90 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88060981 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87787039 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87644588 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84914170 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84417852 |
| 95 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83950662 |
| 96 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83914766 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80462068 |
| 98 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79698772 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79078215 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77467177 |
| 101 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77031771 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75188616 |
| 103 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74747690 |
| 104 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73055808 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72824520 |
| 106 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72627176 |
| 107 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.72132344 |
| 108 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.71953564 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71016549 |
| 110 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.70363365 |
| 111 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69629203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.75023866 |
| 2 | * MP0001800_abnormal_humoral_immune | 5.24028566 |
| 3 | * MP0001790_abnormal_immune_system | 4.91708382 |
| 4 | * MP0005387_immune_system_phenotype | 4.91708382 |
| 5 | MP0000685_abnormal_immune_system | 4.18402829 |
| 6 | * MP0002452_abnormal_antigen_presenting | 3.86333525 |
| 7 | MP0003303_peritoneal_inflammation | 3.54997719 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.19881653 |
| 9 | * MP0002723_abnormal_immune_serum | 3.15098516 |
| 10 | * MP0002420_abnormal_adaptive_immunity | 3.12200891 |
| 11 | * MP0002398_abnormal_bone_marrow | 3.07498387 |
| 12 | * MP0001819_abnormal_immune_cell | 3.00059586 |
| 13 | MP0005671_abnormal_response_to | 2.95910443 |
| 14 | * MP0000716_abnormal_immune_system | 2.77420435 |
| 15 | * MP0000689_abnormal_spleen_morphology | 2.75914247 |
| 16 | * MP0002429_abnormal_blood_cell | 2.26544616 |
| 17 | * MP0002722_abnormal_immune_system | 2.25741304 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.24235921 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.14096351 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.06441260 |
| 21 | MP0002166_altered_tumor_susceptibility | 2.05502166 |
| 22 | MP0004808_abnormal_hematopoietic_stem | 1.94167015 |
| 23 | * MP0005025_abnormal_response_to | 1.86324374 |
| 24 | MP0001873_stomach_inflammation | 1.85594056 |
| 25 | MP0008057_abnormal_DNA_replication | 1.82610014 |
| 26 | MP0002419_abnormal_innate_immunity | 1.79777688 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.74799499 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.71146852 |
| 29 | MP0002405_respiratory_system_inflammati | 1.67623172 |
| 30 | MP0003724_increased_susceptibility_to | 1.67510489 |
| 31 | MP0004510_myositis | 1.66777424 |
| 32 | MP0003436_decreased_susceptibility_to | 1.66136843 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.56200969 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.54586524 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.52879515 |
| 36 | MP0001853_heart_inflammation | 1.52380129 |
| 37 | MP0004947_skin_inflammation | 1.47973815 |
| 38 | MP0006054_spinal_hemorrhage | 1.44875768 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.40034467 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.36947302 |
| 41 | MP0005451_abnormal_body_composition | 1.35347524 |
| 42 | MP0002006_tumorigenesis | 1.32366725 |
| 43 | MP0001879_abnormal_lymphatic_vessel | 1.31894892 |
| 44 | MP0005310_abnormal_salivary_gland | 1.31726782 |
| 45 | MP0003077_abnormal_cell_cycle | 1.30096608 |
| 46 | MP0002933_joint_inflammation | 1.29856694 |
| 47 | MP0003866_abnormal_defecation | 1.28866232 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.22564526 |
| 49 | MP0005464_abnormal_platelet_physiology | 1.17677646 |
| 50 | MP0005645_abnormal_hypothalamus_physiol | 1.17639773 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.17518922 |
| 52 | MP0003787_abnormal_imprinting | 1.14586478 |
| 53 | * MP0009785_altered_susceptibility_to | 1.14552495 |
| 54 | * MP0002019_abnormal_tumor_incidence | 1.13067379 |
| 55 | MP0010352_gastrointestinal_tract_polyps | 1.12932471 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.12350580 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.11523964 |
| 58 | MP0009278_abnormal_bone_marrow | 1.07027703 |
| 59 | MP0004381_abnormal_hair_follicle | 1.03902106 |
| 60 | MP0003091_abnormal_cell_migration | 1.02056754 |
| 61 | MP0008961_abnormal_basal_metabolism | 0.97711167 |
| 62 | MP0002132_abnormal_respiratory_system | 0.96278131 |
| 63 | MP0002909_abnormal_adrenal_gland | 0.94926950 |
| 64 | * MP0002136_abnormal_kidney_physiology | 0.90554912 |
| 65 | MP0001348_abnormal_lacrimal_gland | 0.85093525 |
| 66 | MP0003111_abnormal_nucleus_morphology | 0.84193082 |
| 67 | MP0005174_abnormal_tail_pigmentation | 0.84162982 |
| 68 | MP0002928_abnormal_bile_duct | 0.83108098 |
| 69 | MP0005076_abnormal_cell_differentiation | 0.82678555 |
| 70 | MP0003045_fibrosis | 0.82410191 |
| 71 | MP0003693_abnormal_embryo_hatching | 0.81584175 |
| 72 | MP0000858_altered_metastatic_potential | 0.81266074 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.81219479 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.75809347 |
| 75 | MP0000490_abnormal_crypts_of | 0.74710898 |
| 76 | MP0002139_abnormal_hepatobiliary_system | 0.71792647 |
| 77 | * MP0008469_abnormal_protein_level | 0.70812664 |
| 78 | MP0005621_abnormal_cell_physiology | 0.70731685 |
| 79 | MP0003566_abnormal_cell_adhesion | 0.70643851 |
| 80 | * MP0000350_abnormal_cell_proliferation | 0.66541025 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 0.66368404 |
| 82 | MP0001545_abnormal_hematopoietic_system | 0.66368404 |
| 83 | MP0006082_CNS_inflammation | 0.66214974 |
| 84 | MP0002138_abnormal_hepatobiliary_system | 0.62133373 |
| 85 | MP0001730_embryonic_growth_arrest | 0.61513958 |
| 86 | MP0000313_abnormal_cell_death | 0.61407258 |
| 87 | MP0004957_abnormal_blastocyst_morpholog | 0.59318764 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.58211730 |
| 89 | MP0009763_increased_sensitivity_to | 0.56760979 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.54583006 |
| 91 | MP0002009_preneoplasia | 0.54213790 |
| 92 | MP0001663_abnormal_digestive_system | 0.53627228 |
| 93 | MP0005166_decreased_susceptibility_to | 0.53098996 |
| 94 | MP0003453_abnormal_keratinocyte_physiol | 0.52212979 |
| 95 | MP0000609_abnormal_liver_physiology | 0.52057411 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.52000958 |
| 97 | MP0001851_eye_inflammation | 0.50365166 |
| 98 | MP0008058_abnormal_DNA_repair | 0.50200459 |
| 99 | * MP0000249_abnormal_blood_vessel | 0.49524190 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.49315361 |
| 101 | MP0005381_digestive/alimentary_phenotyp | 0.49041882 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.47396379 |
| 103 | MP0005384_cellular_phenotype | 0.47180906 |
| 104 | MP0008260_abnormal_autophagy | 0.46527538 |
| 105 | MP0002163_abnormal_gland_morphology | 0.46135201 |
| 106 | MP0001784_abnormal_fluid_regulation | 0.45848850 |
| 107 | MP0003279_aneurysm | 0.45777607 |
| 108 | MP0000372_irregular_coat_pigmentation | 0.45734637 |
| 109 | MP0004883_abnormal_blood_vessel | 0.45529251 |
| 110 | * MP0002083_premature_death | 0.45162658 |
| 111 | * MP0008874_decreased_physiological_sensi | 0.44701908 |
| 112 | MP0001986_abnormal_taste_sensitivity | 0.42913519 |
| 113 | MP0002168_other_aberrant_phenotype | 0.42173034 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.42063767 |
| 115 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.41864876 |
| 116 | MP0009115_abnormal_fat_cell | 0.41724287 |
| 117 | MP0009764_decreased_sensitivity_to | 0.41248778 |
| 118 | MP0002693_abnormal_pancreas_physiology | 0.41090723 |
| 119 | MP0000371_diluted_coat_color | 0.40961517 |
| 120 | MP0000733_abnormal_muscle_development | 0.40244161 |
| 121 | MP0009931_abnormal_skin_appearance | 0.40123990 |
| 122 | MP0001533_abnormal_skeleton_physiology | 0.40090431 |
| 123 | MP0010307_abnormal_tumor_latency | 0.39915437 |
| 124 | MP0003252_abnormal_bile_duct | 0.38341836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cellulitis (HP:0100658) | 7.09100165 |
| 2 | Recurrent bronchitis (HP:0002837) | 6.72940017 |
| 3 | Verrucae (HP:0200043) | 6.52435085 |
| 4 | Papilloma (HP:0012740) | 6.52435085 |
| 5 | Colitis (HP:0002583) | 6.19967600 |
| 6 | * Gastrointestinal stroma tumor (HP:0100723) | 6.16432471 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 5.27963670 |
| 8 | Inflammation of the large intestine (HP:0002037) | 5.15751991 |
| 9 | Recurrent viral infections (HP:0004429) | 5.11424788 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 5.01579239 |
| 11 | Meningitis (HP:0001287) | 4.88985730 |
| 12 | Small epiphyses (HP:0010585) | 4.87883532 |
| 13 | IgM deficiency (HP:0002850) | 4.87479533 |
| 14 | Chronic sinusitis (HP:0011109) | 4.83432676 |
| 15 | Abnormality of B cell number (HP:0010975) | 4.58817186 |
| 16 | B lymphocytopenia (HP:0010976) | 4.58817186 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.57999251 |
| 18 | * Recurrent sinusitis (HP:0011108) | 4.44891337 |
| 19 | Osteomyelitis (HP:0002754) | 4.26143017 |
| 20 | Recurrent pneumonia (HP:0006532) | 4.07492523 |
| 21 | * Lymphopenia (HP:0001888) | 4.06100276 |
| 22 | Recurrent lower respiratory tract infections (HP:0002783) | 3.97795233 |
| 23 | IgA deficiency (HP:0002720) | 3.97548839 |
| 24 | Thyroiditis (HP:0100646) | 3.97266117 |
| 25 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.89312128 |
| 26 | Bronchitis (HP:0012387) | 3.86046095 |
| 27 | Chronic otitis media (HP:0000389) | 3.81160538 |
| 28 | * Emphysema (HP:0002097) | 3.76824604 |
| 29 | Sepsis (HP:0100806) | 3.71559114 |
| 30 | Mitral stenosis (HP:0001718) | 3.68665546 |
| 31 | Vertebral arch anomaly (HP:0008438) | 3.63535510 |
| 32 | Recurrent fungal infections (HP:0002841) | 3.33075026 |
| 33 | Abnormality of macrophages (HP:0004311) | 3.29055525 |
| 34 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.22517909 |
| 35 | * Recurrent otitis media (HP:0000403) | 3.19663554 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.19106007 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.19106007 |
| 38 | Abnormality of the fingertips (HP:0001211) | 3.13709461 |
| 39 | Flattened epiphyses (HP:0003071) | 3.12962896 |
| 40 | * Vasculitis (HP:0002633) | 3.08410039 |
| 41 | IgG deficiency (HP:0004315) | 3.07279131 |
| 42 | Abnormality of the prostate (HP:0008775) | 3.02069857 |
| 43 | * Restrictive lung disease (HP:0002091) | 2.95317324 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.92478518 |
| 45 | Viral hepatitis (HP:0006562) | 2.92150615 |
| 46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.85049290 |
| 47 | Recurrent bacterial skin infections (HP:0005406) | 2.83160743 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.80286358 |
| 49 | T lymphocytopenia (HP:0005403) | 2.75853474 |
| 50 | Urticaria (HP:0001025) | 2.75221881 |
| 51 | Abnormality of T cells (HP:0002843) | 2.74101276 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 2.68128611 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.67825768 |
| 54 | Chronic diarrhea (HP:0002028) | 2.66602805 |
| 55 | Ulnar bowing (HP:0003031) | 2.65793941 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.61481785 |
| 57 | Abnormality of T cell physiology (HP:0011840) | 2.61475935 |
| 58 | Skin rash (HP:0000988) | 2.57361930 |
| 59 | Abnormality of the intervertebral disk (HP:0005108) | 2.56849408 |
| 60 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.56505314 |
| 61 | Absent epiphyses (HP:0010577) | 2.56505314 |
| 62 | Chest pain (HP:0100749) | 2.54944243 |
| 63 | Recurrent skin infections (HP:0001581) | 2.54718076 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.54458639 |
| 65 | Irregular vertebral endplates (HP:0003301) | 2.53796802 |
| 66 | Arthropathy (HP:0003040) | 2.37314867 |
| 67 | Abnormality of the pleura (HP:0002103) | 2.35268303 |
| 68 | * Lymphoma (HP:0002665) | 2.33782326 |
| 69 | Increased IgM level (HP:0003496) | 2.29889402 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.26937463 |
| 71 | Skin ulcer (HP:0200042) | 2.25842262 |
| 72 | Myositis (HP:0100614) | 2.23200811 |
| 73 | Optic neuritis (HP:0100653) | 2.23009525 |
| 74 | Retrobulbar optic neuritis (HP:0100654) | 2.23009525 |
| 75 | Hypertensive crisis (HP:0100735) | 2.19740373 |
| 76 | * Leukopenia (HP:0001882) | 2.19398352 |
| 77 | Neutropenia (HP:0001875) | 2.18354241 |
| 78 | Abnormality of the peritoneum (HP:0002585) | 2.16714379 |
| 79 | Abnormality of male internal genitalia (HP:0000022) | 2.13821683 |
| 80 | Encephalitis (HP:0002383) | 2.12645055 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.10059271 |
| 82 | Hypoplasia of the thymus (HP:0000778) | 2.08606194 |
| 83 | Gingivitis (HP:0000230) | 2.08146368 |
| 84 | Orchitis (HP:0100796) | 2.07900154 |
| 85 | Limited elbow extension (HP:0001377) | 2.05678871 |
| 86 | Hemoptysis (HP:0002105) | 2.03206387 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02909817 |
| 88 | Pustule (HP:0200039) | 2.01951107 |
| 89 | Thrombocytosis (HP:0001894) | 2.01304237 |
| 90 | Nasal polyposis (HP:0100582) | 2.01254954 |
| 91 | * Arthralgia (HP:0002829) | 2.01113225 |
| 92 | Papilledema (HP:0001085) | 2.00469338 |
| 93 | Agammaglobulinemia (HP:0004432) | 10.8176698 |
| 94 | Prolonged bleeding time (HP:0003010) | 1.97084029 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 1.94859632 |
| 96 | Pulmonary fibrosis (HP:0002206) | 1.94513107 |
| 97 | Spontaneous hematomas (HP:0007420) | 1.92637494 |
| 98 | Fatigue (HP:0012378) | 1.90547508 |
| 99 | Increased IgE level (HP:0003212) | 1.89246007 |
| 100 | Abnormality of the vertebral endplates (HP:0005106) | 1.88407844 |
| 101 | Hypergammaglobulinemia (HP:0010702) | 1.87857385 |
| 102 | Teleangiectasia of the skin (HP:0100585) | 1.86161420 |
| 103 | Premature loss of primary teeth (HP:0006323) | 1.86019724 |
| 104 | Chronic obstructive pulmonary disease (HP:0006510) | 1.83803191 |
| 105 | Obstructive lung disease (HP:0006536) | 1.83803191 |
| 106 | Eosinophilia (HP:0001880) | 1.83607058 |
| 107 | Barrel-shaped chest (HP:0001552) | 1.83072889 |
| 108 | Hematochezia (HP:0002573) | 1.82991576 |
| 109 | Epistaxis (HP:0000421) | 1.82495233 |
| 110 | Villous atrophy (HP:0011473) | 1.80300481 |
| 111 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80300481 |
| 112 | Basal cell carcinoma (HP:0002671) | 1.79770349 |
| 113 | Eczematoid dermatitis (HP:0000976) | 1.77965177 |
| 114 | Autoimmune hemolytic anemia (HP:0001890) | 1.77773290 |
| 115 | Dehydration (HP:0001944) | 1.77685695 |
| 116 | Squamous cell carcinoma (HP:0002860) | 1.73543165 |
| 117 | Aortic regurgitation (HP:0001659) | 1.72969723 |
| 118 | Pulmonary embolism (HP:0002204) | 1.71852187 |
| 119 | Hepatitis (HP:0012115) | 1.71464609 |
| 120 | Vertebral clefting (HP:0008428) | 1.71179749 |
| 121 | Long eyelashes (HP:0000527) | 1.69045745 |
| 122 | Pulmonary infiltrates (HP:0002113) | 1.66641047 |
| 123 | Facial diplegia (HP:0001349) | 1.65618027 |
| 124 | Granulocytopenia (HP:0001913) | 1.63091135 |
| 125 | Abnormality of the nasal mucosa (HP:0000433) | 1.62439742 |
| 126 | Xerostomia (HP:0000217) | 1.62126213 |
| 127 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.55255182 |
| 128 | Acrocyanosis (HP:0001063) | 1.55091559 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.70360267 |
| 2 | MAP3K10 | 5.31798174 |
| 3 | GRK6 | 3.76452071 |
| 4 | ERN1 | 3.75032295 |
| 5 | CSF1R | 2.85062518 |
| 6 | BLK | 2.83980866 |
| 7 | PRPF4B | 2.83440241 |
| 8 | SYK | 2.79371516 |
| 9 | RIPK4 | 2.62261692 |
| 10 | SIK2 | 2.50590701 |
| 11 | MAP3K13 | 2.47050103 |
| 12 | STK10 | 2.41767097 |
| 13 | LRRK2 | 2.38787718 |
| 14 | EEF2K | 2.01027520 |
| 15 | SMG1 | 1.99889661 |
| 16 | CDK12 | 1.88285428 |
| 17 | MAP3K14 | 1.79258463 |
| 18 | JAK1 | 1.68253151 |
| 19 | TYK2 | 1.64830573 |
| 20 | BMPR2 | 1.39494146 |
| 21 | * LYN | 1.37624742 |
| 22 | MARK3 | 1.35324666 |
| 23 | HCK | 1.30703247 |
| 24 | SIK3 | 1.30455425 |
| 25 | MST4 | 1.30427647 |
| 26 | NME2 | 1.24130323 |
| 27 | GRK1 | 1.23740682 |
| 28 | PASK | 1.22243664 |
| 29 | CLK1 | 1.18521003 |
| 30 | CSK | 1.18297823 |
| 31 | EIF2AK3 | 1.17485440 |
| 32 | * BTK | 1.17443595 |
| 33 | BRD4 | 1.15159351 |
| 34 | NEK2 | 1.14229017 |
| 35 | NEK9 | 1.07287359 |
| 36 | ITK | 1.05934758 |
| 37 | FES | 1.04858248 |
| 38 | KIT | 1.04696626 |
| 39 | SIK1 | 1.02012565 |
| 40 | PRKCQ | 0.99868437 |
| 41 | IKBKB | 0.97767082 |
| 42 | CDK4 | 0.97039374 |
| 43 | PRKCH | 0.95830964 |
| 44 | PIM1 | 0.94858540 |
| 45 | CDC42BPA | 0.94625456 |
| 46 | LCK | 0.94233327 |
| 47 | TBK1 | 0.94229808 |
| 48 | JAK3 | 0.92093058 |
| 49 | TRIB3 | 0.90738054 |
| 50 | CDK19 | 0.90422079 |
| 51 | TNK2 | 0.87974623 |
| 52 | IRAK3 | 0.84355762 |
| 53 | ZAP70 | 0.84077738 |
| 54 | TEC | 0.83420578 |
| 55 | TXK | 0.82938493 |
| 56 | PRKD2 | 0.78914316 |
| 57 | FGFR3 | 0.77267083 |
| 58 | ALK | 0.76739022 |
| 59 | MATK | 0.75686726 |
| 60 | MAPK12 | 0.74308682 |
| 61 | STK4 | 0.73008633 |
| 62 | HIPK2 | 0.72295160 |
| 63 | MAPK7 | 0.71421684 |
| 64 | TGFBR2 | 0.71336862 |
| 65 | WNK1 | 0.70617257 |
| 66 | IRAK4 | 0.68600768 |
| 67 | PKN2 | 0.67398120 |
| 68 | MAP3K7 | 0.65966684 |
| 69 | JAK2 | 0.65723224 |
| 70 | MELK | 0.62188221 |
| 71 | CDK9 | 0.61763826 |
| 72 | DYRK1B | 0.60389931 |
| 73 | PRKD1 | 0.59429318 |
| 74 | CAMK1G | 0.55251747 |
| 75 | PDK1 | 0.54782277 |
| 76 | TLK1 | 0.54126180 |
| 77 | FRK | 0.54068372 |
| 78 | IRAK2 | 0.53807750 |
| 79 | RPS6KA4 | 0.52952820 |
| 80 | MAP2K2 | 0.52523180 |
| 81 | CHUK | 0.52445264 |
| 82 | VRK1 | 0.50566677 |
| 83 | MAP3K11 | 0.49701216 |
| 84 | PDPK1 | 0.49200633 |
| 85 | FYN | 0.47990741 |
| 86 | FGFR4 | 0.46069527 |
| 87 | MAPK4 | 0.45926126 |
| 88 | RPS6KB2 | 0.45398847 |
| 89 | MAP3K1 | 0.45187039 |
| 90 | IRAK1 | 0.42947719 |
| 91 | MAP3K9 | 0.42369652 |
| 92 | MAPK11 | 0.42053760 |
| 93 | MAP3K8 | 0.41857261 |
| 94 | CAMK1D | 0.41128258 |
| 95 | IKBKE | 0.40421323 |
| 96 | TAOK2 | 0.39562437 |
| 97 | KSR2 | 0.39562251 |
| 98 | CSNK1A1L | 0.36404815 |
| 99 | TAOK1 | 0.36371125 |
| 100 | TAOK3 | 0.35957824 |
| 101 | CHEK1 | 0.35861332 |
| 102 | CSNK1D | 0.35508826 |
| 103 | MARK2 | 0.34635489 |
| 104 | MAPKAPK2 | 0.34443190 |
| 105 | PIK3CG | 0.33997245 |
| 106 | SGK3 | 0.33925970 |
| 107 | MAP2K3 | 0.33885104 |
| 108 | FGR | 0.33055313 |
| 109 | FGFR2 | 0.32229585 |
| 110 | EGFR | 0.32170720 |
| 111 | MAP2K1 | 0.31831421 |
| 112 | * ABL1 | 0.30925453 |
| 113 | PRKCI | 0.30824356 |
| 114 | RPS6KA5 | 0.30620517 |
| 115 | CDK6 | 0.30026308 |
| 116 | PTK6 | 0.29093447 |
| 117 | ATR | 0.27856273 |
| 118 | SCYL2 | 0.27535519 |
| 119 | TESK2 | 0.27320600 |
| 120 | * INSR | 0.27232229 |
| 121 | NLK | 0.26450297 |
| 122 | ICK | 0.25829462 |
| 123 | CCNB1 | 0.25620522 |
| 124 | DYRK3 | 0.25542977 |
| 125 | MAPK3 | 0.21316438 |
| 126 | CAMKK1 | 0.21212544 |
| 127 | YES1 | 0.20866948 |
| 128 | ZAK | 0.20387746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.51082208 |
| 2 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 6.22043663 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.43876464 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.20002889 |
| 5 | Asthma_Homo sapiens_hsa05310 | 4.13042077 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.99270642 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.38812482 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.97325567 |
| 9 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.63583715 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58076972 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56182798 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.41934525 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.14409770 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05204457 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.04432876 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.01956658 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.93146230 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74681795 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.74259076 |
| 20 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.70237284 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.65762112 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.48962839 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.48057615 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47289398 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46579449 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.35342702 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.33523678 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25730605 |
| 29 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.24794975 |
| 30 | DNA replication_Homo sapiens_hsa03030 | 1.24671946 |
| 31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23103410 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22587172 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.21656980 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18037503 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.12916095 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09971267 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09799537 |
| 38 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09161672 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06793498 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.05987302 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05893524 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03961612 |
| 43 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03619223 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 0.99175285 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99052759 |
| 46 | Apoptosis_Homo sapiens_hsa04210 | 0.97123988 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.96441651 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94661815 |
| 49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91264912 |
| 50 | Lysine degradation_Homo sapiens_hsa00310 | 0.91053568 |
| 51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.87328581 |
| 52 | Alcoholism_Homo sapiens_hsa05034 | 0.81438273 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80339688 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.79311770 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.76429399 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75496189 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.74995573 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74564133 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73299122 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73262898 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72030330 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70771381 |
| 63 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70508563 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70264806 |
| 65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66159943 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64819869 |
| 67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64367327 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62491432 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.61688329 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61669708 |
| 71 | Homologous recombination_Homo sapiens_hsa03440 | 0.61666690 |
| 72 | Ribosome_Homo sapiens_hsa03010 | 0.61432314 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.61367334 |
| 74 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60978892 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59947423 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57784984 |
| 77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55178315 |
| 78 | Prostate cancer_Homo sapiens_hsa05215 | 0.51840773 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51462019 |
| 80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51170296 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.51135443 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50895953 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50696573 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.48076058 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.48002038 |
| 86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47111634 |
| 87 | Cell cycle_Homo sapiens_hsa04110 | 0.46482101 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46199626 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45243299 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44952938 |
| 91 | Endocytosis_Homo sapiens_hsa04144 | 0.44889864 |
| 92 | Salmonella infection_Homo sapiens_hsa05132 | 0.43538259 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42768077 |
| 94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40700487 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39929387 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39482234 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39231653 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.36988911 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34680533 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.34277458 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32916497 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31238311 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30612316 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30096392 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29845310 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28871932 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.27440762 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26709371 |
| 109 | RNA degradation_Homo sapiens_hsa03018 | 0.26593667 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.26067861 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25972347 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25654236 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25065910 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.22153463 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17055593 |
| 116 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16930590 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14103464 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.10945421 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.09368282 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.07926559 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.06890766 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.03262940 |

